UNC will take part in clinical research sponsored by the National Institutes of Health evaluating treatments for long COVID over a six-month period, according to an Aug. 1 announcement.

The National Institutes of Health announced Monday that it is launching four clinical trials to test the safety and effectiveness of potential long covid treatments, with seven more to begin in ...

The National Institutes of Health is launching several clinical trials related to treatment for long-COVID patients, hoping to evaluate multiple treatments that may finally ease symptoms for ...

He became the main symbol of the rule by experts who imposed lockdowns on America and brooked no scientific debate on Covid. Dr. Fauci has led the National Institute of Allergy and Infectious ...

No, the National Institutes of Health didn’t approve ivermectin as a COVID-19 treatment The NIH did not add the controversial anti-parasitic drug ivermectin to its approved COVID-19 treatment list.

NPR's Mary Louise Kelly talks with Dr. Francis Collins, the National Institutes of Health director, about the surge in coronavirus cases, the reopening of schools this fall and the race for a vaccine.

The National Institutes of Health has recommended against using ivermectin to treat COVID-19 except in clinical trials, but recent social media posts claim the federal agency has quietly OK’d ...

The US National Institutes of Health said Wednesday it’s starting a $470 million study to try to understand what’s become known as long Covid—the long-term, sometimes serious effects of ...

The National Institutes of Health said Monday it has engaged Moderna in "good faith discussions" to resolve a monthslong dispute over the company's patent application that advocates say could ...

No, the National Institutes of Health has not approved ivermectin to treat COVID-19 The NIH says more research is needed to make a determination about whether ivermectin is effective against COVID-19.

According to an official release from the Ministry of Health and Family Welfare, Dr Murhekar, referring to an in-depth study ...